An Animal Model of Type A Cystinuria Due to Spontaneous Mutation in 129S2/SvPasCrl Mice
暂无分享,去创建一个
J. Jaubert | M. Daudon | Dominique Bazin | E. Letavernier | J. Haymann | J. Boffa | L. Baud | L. Mesnard | S. Vandermeersch | E. Thioulouse | M. Livrozet
[1] M. Méchali,et al. A spontaneous Cdt1 mutation in 129 mouse strains reveals a regulatory domain restraining replication licensing , 2013, Nature Communications.
[2] R. Flavell,et al. NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy , 2013, Kidney international.
[3] D. Fotiadis,et al. The SLC3 and SLC7 families of amino acid transporters. , 2013, Molecular aspects of medicine.
[4] H. Anders,et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. , 2013, The Journal of clinical investigation.
[5] M. Daudon,et al. Characterization and some physicochemical aspects of pathological microcalcifications. , 2012, Chemical reviews.
[6] D. Goldfarb,et al. Pathophysiology and treatment of cystinuria , 2010, Nature Reviews Nephrology.
[7] D. Assimos,et al. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. , 2010, Reviews in urology.
[8] A. Evan,et al. Bladder outlet obstruction in male cystinuria mice , 2010, International Urology and Nephrology.
[9] M. Daudon,et al. [Epidemiology of urolithiasis]. , 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.
[10] M. Daudon,et al. [Epidemiology of urolithiasis]. , 2008, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.
[11] M. Palacín,et al. Distinct classes of trafficking rBAT mutants cause the type I cystinuria phenotype. , 2008, Human molecular genetics.
[12] E. Salido,et al. Alanine–glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer , 2006, Proceedings of the National Academy of Sciences.
[13] A. Evan,et al. Renal function in patients with nephrolithiasis. , 2006, The Journal of urology.
[14] R. Goldschmeding,et al. In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] Tianxin Yang,et al. Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. , 2005, American journal of physiology. Renal physiology.
[16] M. Daudon,et al. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] M. Palacín,et al. Slc7a9-deficient mice develop cystinuria non-I and cystine urolithiasis. , 2003, Human molecular genetics.
[18] M. Nehls,et al. A mouse model for cystinuria type I. , 2003, Human molecular genetics.
[19] Li-jun Ma,et al. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. , 2003, Kidney international.
[20] M. Daudon,et al. Cystine crystal volume determination: a useful tool in the management of cystinuric patients , 2003, Urological Research.
[21] M. Gallucci,et al. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. , 2002, Journal of the American Society of Nephrology : JASN.
[22] F. Verrey,et al. Apical heterodimeric cystine and cationic amino acid transporter expressed in MDCK cells. , 2002, American journal of physiology. Renal physiology.
[23] P. Rieu,et al. Medical treatment of cystinuria: critical reappraisal of long-term results. , 2000, The Journal of urology.
[24] Muriel T. Davisson,et al. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice , 1997, Nature Genetics.